Compared with the neoadjuvant chemotherapy group, there was no significant difference of hemoglobin and albumin in the surgery group before colorectal cancer resection (Hemoglobin: 119.0 (g/L) [IQR, 100.0-130.0 (g/L)] vs. 120.0 (g/L) [IQR, 88.8-130.8 (g/L)], p = 0.774; Albumin: 37.50 (g/L) [IQR, 34.70-40.50 (g/L)] vs. 37.05 (g/L) [IQR,33.53-39.45 (g/L)], p = 0.529), which means there is no significant difference in nutritional status between the two groups (Table 2). Here, ALB is linked to colorectal cancer.